19^th International Conference on Diabetes, Endocrinology and Obesity August 21-22, 2020 Florence, Italy

Dr. Xu is a Full Professor in Beijing Normal University-Hong Kong Baptist University United International College (UIC, a full English teaching college in China), Zhuhai Scholar Distinguished Professor, Program Director of Food Science and Technology Program, Associate Director of UIC Key Lab -Laboratory for Health Promotion Mechanism of Medicinal Food and Folk Remedy, author of 182 peer-reviewed papers. Dr. Xu received Ph.D in Food Science from Chungnam National University, South Korea.

Complex relationship among diet, gut microbiota, and human health, health benefits (targeted at aging, cancers, obesity, and diabetes) assessment of phytochemicals from natural products, cellular and molecular mechanisms of bioactive components in disease prevention, Dietary polysaccharides and their functional properties.

Dr. Farid Menaa is an inter- and multi-disciplinary professional with worldwide reputation. He has three international post-doctoral terms in Oncology, Dermatology, and Hematology; MBA Entrepreneurship and MD candidate. During his ongoing career, he has mainly contributed to the identification and functions of new human disease-causing genes and variants, formulated natural products for anti-aging and developed innovative theranostic strategies against cancers, cardiovascular diseases, diabetes, obesity and infectious diseases. He has more than 10 years’ experiences either in the academic, hospitals or industrial sectors.

Preventive Medicine, Personalized Medicine, Translational Medicine, Integrative Medicine, Green Medicine, Nanomedicine, Biotechnology, and Nanotechnology.

Dr. Joseph Fomusi Ndisang is an Associate Professor in the University of Saskatchewan College of Medicine, Department of Physiology. He received postdoctoral training in Physiology at the University of Saskatchewan College of Medicine from 2000-2005. He obtained a PhD in Pharmacology & Toxicology from the University of Florence, Italy, 2000. He obtained a Doctor of Pharmacy degree from University of Florence, Italy in 1995. He has received several distinguished awards and distinctions including: (i) Fellow of the Canadian Cardiovascular Society (FCCS) in 2016, (ii) Fellow of the American Heart Association (FAHA) in 2011; (iii) Fellow of the International College of Angiology (FICA) in 2007; (iv) Young Investigator Award by International College of Angiology (2007); (v) Young Investigator Award by the American Society of Pharmacology & Experimental Therapeutics-Division for Drug Discovery, Development & Regulatory Affairs (2005); (vi) Young Investigator Award by the Society of Experimental Biology and Medicine (2005); (vii) Caroline tum Suden/Frances A Hellebrandt Professional Opportunity Award for Meritorious Research by the American Physiological Society (2005); and (viii) Recognition Award for Meritorious Research by a Young Investigator by the American Physiological Society (2004).

Anatomy, Physiology & Pharmacology

Marcos Roberto Tovani Palone is a Specialist in Pediatric Dentistry - 2010 (Hospital for Rehabilitation of Craniofacial Anomalies, University of São Paulo), Specialist in Syndromes and Craniofacial Anomalies - 2013 (Hospital for Rehabilitation of Craniofacial Anomalies, University of São Paulo), MSc in Orofacial Clefts and Related Anomalies - 2014 (Hospital for Rehabilitation of Craniofacial Anomalies, University of São Paulo), Specialist in Health Management - 2016 (Federal University of São Paulo), PhD in Experimental Pathology (Department of Pathology and Legal Medicine, Faculty of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil).

Cleft lip and palate, Dentistry, Pathology, Public health, Pediatrics, Global Health